## Clinical Diagnosis **Key Point:** This is *Streptococcus pneumoniae* meningitis in an asplenic patient. The CSF profile (lymphocytic pleocytosis, elevated protein, low glucose, and Gram-positive diplococci) is pathognomonic. Asplenia is a major risk factor for invasive pneumococcal disease, including meningitis. ## Why Empirical Triple Therapy Is Mandatory **High-Yield:** In meningitis with suspected pneumococcal etiology, empirical therapy MUST cover: 1. **Penicillin-susceptible *S. pneumoniae*** → Ceftriaxone or cefotaxime 2. **Penicillin-resistant *S. pneumoniae*** → Vancomycin (CSF penetration ~20% at therapeutic serum levels; requires high-dose) 3. **Adjunctive CNS penetration** → Rifampin (synergistic with vancomycin in resistant strains) **Clinical Pearl:** Cephalosporin monotherapy is insufficient for meningitis because: - 3rd-generation cephalosporins have limited CSF penetration (~30% of serum levels) - Resistance to cephalosporins is increasing globally - Vancomycin + rifampin combination is needed for resistant strains to achieve bactericidal CSF levels ## Comparison of Regimens | Regimen | Covers Susceptible | Covers Resistant | CSF Penetration | Guideline Status | |---------|-------------------|------------------|-----------------|------------------| | **Ceftriaxone + vancomycin + rifampin** | ✓ | ✓ | Excellent | **Standard of care** | | Penicillin G alone | ✓ | ✗ | Good | Obsolete (resistance) | | Cefotaxime alone | ✓ | Partial | Moderate | Inadequate for resistant | | Chloramphenicol | ✓ | ✓ | Good | Rarely used (toxicity) | **Mnemonic:** **VCR for Resistant Pneumococcal Meningitis** — Vancomycin + Cephalosporin + Rifampin. ## Dosing for Meningitis - **Ceftriaxone:** 2 g IV 4-hourly (higher than CAP dosing to achieve CSF levels) - **Vancomycin:** 15–20 mg/kg IV 8–12-hourly (target CSF level 15–20 μg/mL; serum trough 15–20 μg/mL) - **Rifampin:** 600 mg IV 12-hourly (adjunctive, synergistic) **Warning:** Do NOT use penicillin G alone or cephalosporin monotherapy for meningitis — resistance is common, and CSF penetration is insufficient without vancomycin + rifampin. [cite:Harrison 21e Ch 297; Robbins 10e Ch 7]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.